NCT01687517View on ClinicalTrials.gov

Efficacy and Safety of Influenza Vaccine During Sarcoidosis

PHASE3CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

October 31, 2014

Conditions
SarcoidosisInfluenza Vaccine
Interventions
DRUG

Seasonal influenza vaccine available for the 2012-2013 vaccine campaign

Single injection of the vaccine at D0 (0.5mL intra-muscularly or subcutaneous for patient under anticoagulant treatment)

Trial Locations (1)

75004

Hotel-Dieu Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01687517 - Efficacy and Safety of Influenza Vaccine During Sarcoidosis | Biotech Hunter | Biotech Hunter